Solaris Endovascular Announces Completion of Enrollment in DEScover Clinical Trial
Solaris Endovascular, Inc. has announced that its DEScover clinical trial evaluating the Solaris DE sirolimus‑eluting covered stent for vascular disease in dialysis access circuits has successfully completed patient enrollment ahead of schedule, marking a key scientific milestone in the company’s development program. Interim six‑month data presented at TCT 2025 showed encouraging target lesion primary patency results and no device‑related serious adverse events, reinforcing the potential clinical impact of the Solaris DE platform as follow‑up matures 
Solaris Endovascular Announces Completion of Enrollment in DEScover Clinical Trial